StonvexLoading…
StonvexStonvexStonvexCore line items from OGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 |
|---|---|---|---|---|
Revenue | $2.58B | $1.81B | $1.53B | $1.65B |
Operating Income | $349.96M | $310.26M | $303.52M | $295.26M |
Net Income | $221.74M | $206.43M | $196.41M | $186.75M |
EPS (Diluted) | $4.08 | $3.85 | $3.68 | $3.51 |
Total Assets | $7.78B | $8.40B | $6.03B | $5.71B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $9.68M | $8.85M | $7.99M | $17.85M |
Free Cash Flow OCF − CapEx | $961.36M | $-2.03B | $-106.84M | $-106.98M |
Shares Outstanding | 55.35M | 53.63M | 53.17M | 52.77M |